Tag:
overactive bladder
Latest Headlines
Latest Headlines
Astellas scores FDA panel nod for overactive bladder drug
Astellas is one step closer to building its blockbuster business in overactive bladder meds.
FDA green-light's Antares' overactive bladder gel; Watson to sell it
Antares Pharma's ($AIS) new topical gel to treat overactive bladder will hit the U.S. commercial market in the spring. FDA approval for the drug variation was announced Dec. 8. Fellow New Jersey
